Health
Novel vectors reduce the risks associated with ocular gene therapies – News-Medical.net
Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development.
Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development. Novel gene vectors now achieve widespread gene delivery and reduce the risks associated with these approaches.
The incidence of genetic mutations that result in rapid deterioration of the ability to see is larger than is generally supposed. For example, on the order of five million people around the world suffer from congenital retinal dystrophies, which often lead…
-
Business24 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News21 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News21 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
General11 hours agoThe right-wing stupidity repeating Liberal Party history